Collegium Pharmaceutical (COLL) Stock Statistics & Valuation Metrics

Collegium Pharmaceutical has a market cap or net worth of $959.77M. The enterprise value is $1.78B.

Collegium Pharmaceutical has 32,142,193 shares outstanding. The number of shares has decreased by -2.65% in one year.

Collegium Pharmaceutical’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 9.77%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.

In the last 12 months, operating cash flow was 198.44M and capital expenditures -1.88M, giving a free cash flow of 196.56M billion.

Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―

Collegium Pharmaceutical upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Collegium Pharmaceutical as a current ratio of 0.95, with Debt / Equity ratio of 360.11%

In the past 12 months, Collegium Pharmaceutical has paid 29.38M in taxes.

Collegium Pharmaceutical EV to EBITDA ratio is 5.01, with an EV/FCF ratio of 8.43.

Collegium Pharmaceutical has $197.77M in cash and marketable securities with $844.21M in debt, giving a net cash position of $646.44M billion.

Gross margin is 57.69%, with operating margin of 26.91%, and net profit margin of 10.96%.

The average price target for Collegium Pharmaceutical is $38.37, which is 11.43% higher than the current price. The consensus rating is Moderate Buy